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DO THE ENDS JUSTIFY THE MEANS?




In recent years, the human papillomavirus (HPV)' has become a focal
point in the media for its effects in young women.2 HPV is a sexually
transmitted infection (STI), which can cause cervical cancer in women and
has infected close to twenty million people. However, men are mere
carriers of the virus.4 In 2006, pharmaceutical producer Merck and Co., Inc.
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1. See Genital HPV Infection - Fact Sheet, CTRS. FOR DISEASE CONTROL &
PREVENTION, http://www.cdc.gov/std/HPV/STDFact-HPV.htm (last visited Oct. 30,
2010) [hereinafter HPV Fact Sheet]. HPV is a virus that contains more than forty
different types. It can infect the genital areas of men and women, including the skin of the
penis, vulva (area outside the vagina), anus, and the linings of the vagina. Id.
2. See generally Bridget J. Kelly, The HPV Vaccine and the Media: How Has the
Topic Been Covered and What are the Effects on Knowledge About the Virus and
Cervical Cancer?, 77 PATIENT EDU. AND COUNSELING 308 (2008). Kelly discusses how
the media has covered the HPV vaccine and how the vaccine was affected by such
coverage. She concludes that media coverage greatly increased after the vaccine was
introduced in 2006; however, an analysis of the coverage reveals that many stories were
incomplete. Id. See generally Abnormal Pap Smears, HPV. CIN, VIN and VAIN,
GYNECOLOGIC ONCOLOGY Assocs., http://franklin.liquidweb.com/-gynoncol/physicians/
mark-a-rettermaier-md/personal-observations/abnormal-pap/ (last visited Nov. 7, 2010).
3. See HPV Fact Sheet, supra note 1.
4. Coco Matters, Oral Sex Can Add to HPV Cancer Risk, TIME (May 11, 2007),
http://www.time.com/time/health/article/0,8599,1619814,00.html; CTRS. FOR DISEASE
CONTROL & PREVENTION, HUMAN PAPILLOMAVIRUS INFORMATION FOR CLINICIANS 1, 6
(Apr. 2007), http://www.cdc.gov/std/hpv/common-clinicians/ClinicianBro-fp.pdf; see
also Tracy S. Dowling, Mandating a Human Papillomavirus Vaccine: An Investigation
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introduced Gardasil@, a vaccine that, when given to adolescent girls before
they become sexually active, can prevent HPV.5 The introduction of the
vaccine prompted major medical, moral and legal debates.6 While doctors
debated the safety and efficacy of the vaccine, religious leaders debated the
potential promiscuity that the availability of the vaccine might encourage.
At the state level, some politicians introduced legislation that would require
girls to be vaccinated for school enrollment; only two such efforts have
become law.8
The debate recently expanded to include discussion of vaccinating men.
In 2009, the Food and Drug Administration (FDA) approved the HPV
vaccine for use in men. This controversial approval initiated heated debate
on public policy, economic, and health grounds for expanding vaccination to
men. Although all states have mandatory vaccination laws for school
enrollment, historically such requirements have sought to protect against
into Whether Such Legislation is Constitutional and Prudent, 34 AM. J.L. & MED. 65, 72
(2008).
5. Letter from Norman W. Baylor, Director, Office of Vaccines Research and
Review, Center for Biologics Evaluation and Research, U.S. Food & Drug Admin., Dep't
of Health & Human Servs., to Dr. Patrick Brill-Edwards, Merck & Co., Inc. (June 8,
2006), available at http://www.fda.gov/BiologicsBloodVaccines/Vaccines/
ApprovedProducts/ucml 1 1283.htm; Press Release, Am. Coll. of Obstetricians and
Gynecologists, Ob-Gyns Recommend HPV Vaccination for Young Girls (Aug. 23,
2010), available at http://www.acog.org/fromhome/publications/pressreleases/nr08-23-
10-3.cfm. See Sean Alfano, What Does Gardasil Mean for Women?, CBS NEWS (Aug.
31, 2009), http://www.cbsnews.com/stories/2006/06/08/health/webmd/mainl695636.
shtml.
6. Gail Javitt, Deena Berkowitz & Lawrence 0. Gostin, Assessing Mandatory HPV
Vaccination: Who Should Call the Shots?, 36 J.L. MED. & ETHIcs 384, 384 (2008).
7. Nancy Gibbs, Defusing the War Over the "Promiscuity" Vaccine, TIME (Jun. 21,
2006), http://www.time.com/time/nation/article/0,8599,1206813,00.html.
8. HPV Vaccine a Suggestion, Not Mandate, in U.S., MSNBC (Aug. 31, 2009),
http://www.msnbc.msn.com/id/32628957/ns/health-kids-andparenting/.
9. Press Release, Food & Drug Admin., FDA Approves New Indication for
Gardasil to Prevent Genital Warts in Men and Boys, (Oct. 16, 2009), available at
www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucml87003.htm [hereinafter
FDA Approves New Indication for Gardasil]; see FDA Approves Merck's Gardasilfor
Boys, MSNBC (Oct. 16, 2009), http://www.msnbc.msn.com/id/33347708.
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communicable diseases such as polio, rubella and the measles. 0 In addition,
such laws must meet the constitutional standards set forth by the United
States Supreme Court in Jacobson v. Massachusetts." Because mandatory
vaccination laws have been successful in the past, it would seem logical that
lawmakers would start introducing laws compelling the HPV vaccine on
men as well as women, as a strategy for protecting against the virus.
Currently, no state has introduced such legislation compelling vaccination
on men. This Note will argue that mandatory HPV vaccination in men
would allow for impermissible government intervention into privacy rights;
that the HPV vaccine has not been studied enough to show long-term safety
or efficacy; and that vaccinating men against HPV is not cost-effective. 12it
has been argued elsewhere that the Jacobson test needs updating," but this
Note accepts the Jacobson five-prong test and argues that the government
should not require men to purchase an expensive vaccine that does little to
protect the public at large. This Note examines the arguments that could be
made in support and in opposition of mandating the vaccine in men using
similar arguments already made in reference to the vaccination of women.
This Note will open with a full discussion of HPV, its connection to
cervical cancer, and its relation to men. Part III will address the historical
and legal reasons for compelling vaccination. The next section will discuss
the HPV vaccine and its recent approval for men. Part V will examine the
debate regarding the HPV vaccine's safety and efficacy, while outlining the
extreme cost of the vaccine and questioning whether it is cost effective to
compel men to be vaccinated. Part VI of this Note addresses privacy rights
and the implications of compelling vaccination. Part VII analyzes the
constitutionality of compelling vaccination, in light of the test set forth in
10. KATHLEEN S. SWENDIMAN, CONG. RESEARCH SERv., RS 21414, MANDATORY
VACCINATIONS: PRECEDENT AND CURRENT LAWS 3 (2009).
11. Jacobson v. Massachusetts, 197 U.S. 11 (1905).
12. See Frederic E. Shaw, New Adolescent Vaccines: Legal and Legislative Issues,
35 J.L. MED. & ETHICS 106, 108-09 (2007).
13. See generally Benjamin Lemke, Why Mandatory Vaccination of Males Against
HPV is Unconstitutional: Offering a New Approach to an Old Problem, 19 B. U. PUB.
INT. L. J. 261 (2010). Lemke argues that as more vaccinations are developed that do not
address pressing needs, the test into whether mandatory vaccinations are constitutional as
laid out in Jacobson v. Massachusetts needs updating. He presents a new "Modified
Hand Formula," a test that balances the key competing concerns inherent in any
discussion of the constitutionality of mandatory vaccinations." Id. at 261. This Note
differs in that it accepts the Jacobson test and discusses the prongs of the test, the
efficacy and safety of the vaccine, and the economic considerations.
I852010
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Jacobson v. Massachusetts. This section also analyzes the HPV vaccine
under the Jacobson factors and determines that mandating the HPV
vaccination in men would likely be held unconstitutional. Part VIII
discusses the burden an expensive vaccine would have on our health care
system and the compulsory vaccination legislation that has been introduced
at the state level. This Note concludes that the government should not
compel men to purchase an expensive vaccine that does little to protect the
public at large when, it is not cost-effective, the safety and efficacy are
questionable, and such action impinges on privacy rights.
1l. INTRODUCING HPV
The Centers for Disease Control and Prevention (CDC) reports that HPV
is the most common STI. 14 An estimated twenty million Americans are
currently infected with HPV,15 yet most are unaware.' 6 According to Dr.
Eileen Dunne from the CDC, one of the leading researchers on HPV and its
vaccine, "there's a lot of misunderstanding about HPV's complex natural
history. It's not that if you get the infection, you get the disease. It is a
common infection, and a lot of them clear [on their own]."17 The CDC
reports that at least fifty percent of sexually active men and women become
infected with HPV at some point in their lives.18 While most cases clear up
without the infected individual ever knowing he was infected, some cases
develop into more serious conditions.19
There are more than one hundred strains of the virus, but only fifteen are
categorized as "high risk" because of their association with cervical cancer,
the eleventh most common cancer in women. 20  "Low risk" strains are
14. HPV Fact Sheet, supra note 1, at 1.
15. Id. at 2. According to the CDC, in ninety percent of cases, a person's immune
system will clear the infection without the infection's manifesting any symptoms. Id. at
1.
16. See id
17. Study Estimates Overall HPV Prevalence in U.S. Women, NAT'L CANCER INST.
(Mar. 6, 2007), http://www.cancer.gov/cancertopics/hpv-prevalence0307.
18. HPV Fact Sheet, supra note 1, at 2.
19. See Study Estimates Overall HPV Prevalence in U.S. Women, supra note 17.
20. Id.; see also Dowling, supra note 4, at 72; see also AM. Soc. HEALTH ASS'N,
FREQUENTLY ASKED QUESTIONS ABOUT CERVICAL CANCER/HPV VACCINE ACCESS IN THE
186
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classified as such when they lead to genital warts in both men and women.21
Certain strains of HPV have also been found to cause rare forms of cancer in
men.22 In 2006, HPV caused cervical cancer in approximately 10,000
American women, resulting in 3,700 deaths. Comparatively, these
numbers are drastically higher worldwide.24 Although the CDC estimates
very high numbers of infected people,25 independent studies by Lisa
Manhart and Dr. Dunne conclude that the prevalence of HPV in women is
around twenty-six percent, which is much lower than CDC estimates.26
These studies also question the effectiveness of current prevention and
treatment options, including the HPV vaccine. 27
Ill. THE PATH TO MANDATORY VACCINATION IN THE UNITED STATES
The historical development of vaccinations is an integral part of this
discussion because it reflects the balancing act American policymakers must
achieve to protect privacy rights while simultaneously looking out for the
interests of the state. As early as the seventeenth century, when the first
reported vaccinations were used in India and China, researchers developed
vaccines as part of an effort to protect the public from communicable
U.S. (Mar. 2007), http://www.ashastd.org/pdfs/HPVFAQ_032007.pdf [hereinafter
ASHA FAQ].
21. HPV Common Infection. Common Reality, CTRS. FOR DISEASE CONTROL &
PREVENTION, http://www.cdc.gov/std/hpv/common-downloads.htm (last visited Oct. 30,
2010); see also HPV Fact Sheet, supra note 1, at 2. The disease manifests itself in a
variety of ways, including warts and other forms of cancer. Id. at 1.
22. See ASHA FAQ, supra note 20; see generally Human Papilloma Virus (HPV),
Cancer, and HPV Vaccines - Frequently Asked Questions, AM. CANCER Soc'v,
http://www.cancer.org/Cancer/CancerCauses/OtherCarcinogens/InfectiousAgents/HPV/H
umanPapillomaVirusandHPVVaccinesFAQ/index (last visited Oct. 2010), [hereinafter
A CS FAQ]; see generally HPV Fact Sheet, supra note 1.
23. Dowling, supra note 4, at 70.
24. See Dowling, supra note 4, at 70. Cervical cancer is the second most common
form of cancer in women resulting in 470,000 new cases and 233,000 deaths. Id.
25. HPV Fact Sheet, supra note 1, at 2.
26. See Dowling, supra note 4, at 70-72.
27. Id.
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28diseases. Modem vaccination practices are credited to the eighteenth
century work of Dr. Edward Jenner, 29 whose work gave rise to the field of
vaccinology30 and the development of campaigns aimed at combating the
spread of communicable diseases. In 1827, Boston became the first city to
require vaccination against small pox for school enrollment. 32
The modem era of compulsory vaccination began in the 1970s to control
indigenous measles, a communicable disease.33  State legislatures began
using their authority to impose mandatory vaccination for school attendance
and certain jobs. 34 Programs such as "no shots, no school," which instituted
mandatory vaccination requirements for school attendance, resulted in high
levels of childhood immunization due to strict enforcement. 35 A widely
used example illustrating this point took place in Texarkana, Texas, close to
the Arkansas border.36  In 1971, Texarkana did not require measles
vaccinations, but its neighboring town in Arkansas bearing the same name
28. See generally OLE LUND ET AL., IMMUNOLOGICAL BIOINFORMATIC (Sorin Istrail et
al. eds., 2005). Lund notes that the earliest documented examples of vaccination are from
India and China from the seventeenth century. These vaccinations were created using
powdered scabs from people infected with smallpox, which use to be a common disease
that killed twenty to thirty percent of infected people. Smallpox was responsible for eight
to twenty percent of all deaths in several European countries in the 18th century. Id.
29. Alexandra Minna Stern & Howard Market, The History of Vaccines and
Immunization: Familiar Patterson, New Challenges, 24 HEALTH AFFAIRS 611, 612
(2005).
30. AM. HERITAGE MED. DICTIONARY (3d ed. 2007) (defining vaccinology as the
"science or methodology of vaccine development").
31. Stern & Market, supra note 29.
32. SWENDIMAN, supra note 10, at 3.
33. Shaw, supra note 12.
34. James J. Hodge & Lawrence 0. Gostin, School Vaccination Requirements:
Historical, Social, and Legal Perspectives, 90 Ky. L.J. 831, 840-45 (2002); see
SWENDIMAN, supra note 10, at 4.
35. Sylvia Law, Human Papillomavirus Vaccination, Private Choice and Public
Health, 41 U.C. DAVIS L. REV. 1731, 1746 (2008); see National Childhood Vaccine
Injury Act of 1986, 42 U.S.C. §§ 300aa-1, 300aa-22 (2000).
36. See Law, supra 35, at 1745-46.
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did. Consequently, when a measles outbreak began, the infection rate in
Texarkana, Texas was twelve times higher than the rate in Arkansas.3 8 In
light of these results, Texas mandated vaccination for school attendance,
which was challenged and upheld by the Supreme Court in 1973.39
Prior to the 1980s, lax enforcement of vaccination requirements by school
officials resulted in a low number of immunized children.40 However, once
school officials were pressured by health officials to enforce these policies,
the number of children immunized noticeably increased. 4' Between 1968
and 1981, the percentage of states using a mandatory vaccination system
increased from fifty to 100%.42 These policies have been extended further to
compel vaccination for day care and college attendance, and as an aspect of
approved home-schooling, resulting in an increase in vaccination for those
groups as well. 43 Currently, only Virginia and the District of Columbia
require STI vaccination as a precursor for the enrollment of adolescent
girls. 44 Not only is adding a vaccine aimed at preventing against the transfer
of a STI very different from the traditional list of communicable diseases,
but further extending the mandate to carriers of the disease would be
unconstitutional and unprecedented.
IV. THE CONTROVERSIAL HPV VACCINE
A. The History of the HPV Vaccine
Technological advances have helped researchers develop preventive steps
to protect the public from contracting communicable, and now non-
37. Id.
38. Id. at 1746.
39. Id.
40. Id.
41. Id. Children and teens are also more likely to be immunized when policies are
implemented for early-child education and extend through college admissions. Law,
supra note 35, at 1746
42. Id.
43. Id.
44. Id. at 1762 ; see HPV Vaccine a Suggestion, Not Mandate, in U.S., supra note 8.
2010 I89
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communicable, viruses.45  Merck tendered its ajplication for the HPV
vaccine, Gardasil@, to the FDA in December 2005. After the vaccine went
through the FDA's "fast-track" approval process - lasting only six months -
Gardasil was approved for use in females aged nine to twenty-six for the
prevention of different forms of cancer.4 7 In 2009, the FDA approved
Cervarix@, an HPV vaccine manufactured by GlaxoSmithKline, for use in
48women.
Following the approval of Gardasil@, the Advisory Committee on
Immunization Practices (ACIP), a group of fifteen experts chosen by the
Secretary of the U.S. Department of Health and Human Services to provide
guidance on the control of "vaccine-preventable diseases," 49 recommended
45. See Ursula Schlipk6ter & Antoine Flahault, Communicable Diseases:
Achievements and Challenges for Public Health, 32 PUB. HEALTH REv. 90, 90, 97(2010).
46. See Nellie Bristol, HPV Vaccine: Should it be Mandatory for School Girls?, 17
CONG. Q. RESEARCHER 409, 411 (2007). Bristol explains the connection between sexual
intercourse and the development of cervical cancer. In the nineteenth century, physicians
noticed that married women and prostitutes, not nuns, contracted the disease. In 1943,
Dr. George Papanicolaou, a Greek physician and anatomist in the United States,
developed a test that detects signs of cervical and uterine cancer before symptoms appear.
The "pap smear," bearing his name, is still used today as the primary preventative
measure. See RAPID PUB. HEALTH POL'Y RESPONSE PROJECT, SCH. OF PUB. HEALTH &
HEALTH SERVS. OF THE GEO. WASH. UNIv., HPV VACCINATION: SHOULD IT BE
RECOMMENDED OR REQUIRED? 1 (2007), http://www.gwumc.edu sphhs/
about/rapidresponse/download/HPVVaccinePaper_(January_2007).pdf.
47. Ariel Pizzitola, The Constitutionality of Opting out of Adolescent Sex: HPV
Vaccine-Mandate Legislation Raises Constitutional Questions, 24 J. CONTEMP. HEALTH
L. & POL'Y 399, 399 (2007); see also Press Release, Food & Drug Admin., FDA
Licenses New Vaccine for Prevention of Cervical Cancer and Other Diseases in Females
Caused by Human Papillomavirus: Rapid Approval Marks Major Advancement in Public
Health (June 8, 2006), http://www.fda.gov/bbs/topics/NEWS/2006/NEW01385.htm
[hereinafter FDA Licenses New Vaccine for Prevention of Cervical Cancer].
48. See Press Release, GlaxoSmithKline, FDA Approves Cervarix@,
GlaxoSmithKline's Cervical Cancer Vaccine, Oct. 16, 2009, available at
http://www.gsk.com/medialpressreleases/2009/2009_pressrelease 10112.htm; see also
FDA Approves New Indication for Gardasil, supra note 9. This Note will discuss the
controversy surrounding the HPV vaccine, specifically discussing Gardasil because of the
availability of data and research.
49. See Description of Advisory Committee on Immunization Practices, CTRS. FOR
DISEASE CONTROL & PREVENTION, http://www.cdc.gov/vaccines/recs/ACIP/default.htm
(last visited Oct. 2010). The Committee makes recommendations "for the routine
190
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Gardasil@ for routine use by girls aged eleven and twelve in the prevention
of HPV, as well as young women aged thirteen to twenty-six on a "catch up"
50
schedule to ensure that all women could have access to the vaccine.
ACIP's recommendations allowed physicians to distribute the vaccine and
recommend it for use in young women, opening the door to the next step:
imposing school-based mandates.
B. Extending the HP V Vaccine to Men
After the FDA approved Gardasil@ for use in women, Merck continued
its research, focusing on extending the vaccine to men.51  Doctors and
researchers noted, while discussing a possible mandate for women, that
requiring girls to be vaccinated, but not requiring men, who make up "half
the relevant infectious population," to be vaccinated would not achieve
"herd immunity," which is essential to stopping the spread of viruses.52
"Herd immunity" is achieved when an "entire community is protected
against a contagion because a sufficiently large percentage of the group is
immune."5 Proponents of extending the vaccine to men would argue that
until both sexes are vaccinated, achieving "herd immunity," the virus would
continue to spread. 54
On October 16, 2009, after months of lobbying from both sides of the
issue, the FDA approved Gardasil@ for use in the male population. 5  The
administration of vaccines to children and adults in the civilian population;
recommendations include age for vaccine administration, number of doses and dosing
interval, and precautions and contraindications." Id. The overall goals of the ACIP are to
provide advice that will lead to a reduction in the incidence of vaccine preventable
diseases in the United States, and an increase in the safe use of vaccines and related
biological products. Id.
50. See ASHA FAQ, supra note 20; see generallv HPV Fact Sheet, supra note 1.
51. See What Does Gardasil Mean for Women, supra note 5. On the heels of the
FDA approving Gardasil for use in women, the company began researching the
possibility of extending it to men and older women. Id.
52. See Law, supra note 35, at 1761.
53. Id. at 1762.
54. Id. at 1763.
55. See FDA Approves New Indication for Gardasil, supra note 9; see also FDA
Approves Merck's Gardasil for Boys, supra note 9.
2010 I191
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HPV vaccine could prevent some rare forms of cancers in men, such as
penile and anal cancer, which normally occur in men engaged in
homosexual behavior. 56 Two weeks later, the ACIP approved the vaccine
only as a "permissive" rather than "routine" recommendation. 57 Now men
can protect themselves from HPV, but this does not open the door for the
states to take the unprecedented step of compelling the vaccination of all
men based on the sexual behavior of some, or their status as a carrier of the
virus to the opposite sex.
V. WHAT ABOUT THE EFFICACY, SAFETY AND COST OF THIS VACCINE?
A. Conflicting Reports on the HPV Vaccine's Efficacy
There are conflicting reports regarding the HPV vaccine's efficacy. Since
the vaccine is relatively new and went through the "fast-track" approval
process, additional testing needs to be conducted to determine its efficacy
and safety. Additionally, to impose vaccination on a group of virus carriers,
studies should be required to demonstrate that such action is an essential step
to preventing the spread of the virus. However, based upon studies finding
that ninety percent of women are free from the infection after two years
regardless of treatment, vaccination might not be necessary at all.5s
Mandatory vaccination can have positive results, but mandating it to all men
would be a drastic step.
56. See generally HPV Fact Sheet, supra note 1; see OFFICE ON WOMEN'S HEALTH,
HUMAN PAPILLOMAVIRUS (HPV) AND GENITAL WARTS FAQ 1, http://www.womens
health.gov/faq/human-papillomavirus.pdf.
57. See generally Karla Gale, New Vaccine Schedule Says HPV Vaccine Can be
Given to Prevent Warts in Men, REUTERS (Jan. 4, 2010), http://www.oncolink.org/
resources/article.cfm?c=3&s=8&ss=23&Year-2010&Month=01&id=16619. CDC staff
reviewed the difference between an affirmative (routine) and permissive recommendation
in terms of actions required. An affirmative recommendation requires physicians to offer
the vaccine proactively to a VFC-eligible child; a permissive does not. Under both
circumstances providers are expected to offer the vaccine if it is requested, but in the case
of a permissive recommendation they can refer elsewhere if they don't stock the vaccine.
Immunization programs are expected to promote affirmative recommendations but not
permissive recommendation and uptake of a permissive recommendation is not
a performance measure for the program. Id.
58. Vaccine Protects Against Virus Linked to HalfofAll Cervical Cancers, NAT'L
CANCER INST. (Nov. 26, 2002), http://www.cancer.gov/clinicaltrials/results/summary/
2002/cervical-cancer-vaccine 1102; see Jessica A. Kahn, Vaccination as a Prevention
Strategy for Human Papillomavirus-Related Diseases, 37 J. ADOLESCENT HEALTH SI 0,
S14 (2005); see also Law, supra note 35, at 1733.
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Addressing the efficacy issue first, the FDA approved a vaccine for use in
adolescents after putting it through the "fast-track" approval process.59 The
FDA conducted only four studies of 21,000 women for efficacy over the
five-year trial period. 60 Additional questions remain, including the duration
of antibody response after vaccination and the impact of vaccination on
cancer screening behavior. It is also unclear how long the vaccine will
protect against HPV: if it is only temporarily effective, then additional
booster shots would be necessary, which would further increase the price.62
These concerns must be addressed before mandating a vaccine for men that
does not fully protect against a non-communicable disease like HPV.
Merck claims that Gardasil@ prevents contraction of four HPV strains:
63types 6, 11, 16 and 18. However, there are over one hundred active strains
of HPV that can cause genital warts and other rare cancers. 4 In addition,
two recent studies question the effectiveness of the HPV vaccine when the
prevalence of HPV in women is closely examined. These studies found that
only twenty-six percent of women have an HPV strain, compared to fifty
percent as reported by the CDC.65 Additional data from the National Health
59. See FDA Licenses New Vaccine for Prevention of Cervical Cancer, supra note
47; see also, Law, supra note 35, at 1760.
60. See FDA Licenses New Vaccine for Prevention of Cervical Cancer, supra note
47; see also, Law, supra note 35, at 1738.
61. Kahn, supra note 58, at S14. Kahn notes that additional questions remain
concerning provider willingness to recommend the vaccine, the vaccine's acceptability
among parents and adolescents, and the development of effective public health strategies
to guarantee immunization in particular areas. Race, geographic region and other factors
might affect the efficacy of the HPV vaccine. Id.
62. Id.
63. See FDA Licenses New Vaccine for Prevention of Cervical Cancer, supra note
47.
64. See Jennifer Corbett Dooren, Merck Cervical-Cancer Vaccine is Approved for
Use in Women - Gardasil Could Sharply Cut Key Viruses Behind Disease; CDC to Set
Forth Guidelines, WALL ST. J., June 9, 2006, at A 16; see also Press Release,
GlaxoSmithKline, GSK Submits Biologics License Application to U.S. Food and Drug
Administration for Cervarix@ (Mar. 29, 2007), http://www.gsk.com/ControllerServiet?
appld=4&pageld=402&newsid=1000.
65. See Lawrence 0. Gostin & Catherine D. DeAngelis, Mandatory HPV Vaccine:
Public Health vs. Private Wealth, 297 JAMA 17 (2007); see generally Lisa E. Manhart,
Human Papillomavirus Infection Among Sexually Active Young Women in the United
2010 193
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and Nutrition Examination Survey concluded that only 26.8% of women
were infected.66 The study found that 3.4% of its participants were infected
with at least one of the four "hih risk" HPV strands, and that HPV strands
16 and 18 existed in only 1.6%.t7 Reasonable minds could dispute whether
twenty-six percent indicates high or low prevalence, but what these studies
clearly support is that "the Xrevalence of strands of HPV protected by the
vaccine [is] relatively low." As a result, Gardasil@ only prevents infection
in a very small portion of the female population infected with HPV.69 If
Gardasil@ only prevents against infection in a small portion of the female
population, the sex at risk for cervical cancer, then the tenuous step of
compelling vaccination in men, who are mere carriers of the virus, would
constitute a greater burden on men than the reciprocal benefit to women.
B. Questions Still Remain Regarding the HPV Vaccine's Safety
Although general medical community support for the HPV vaccine has
been strong, an editorial in the New England Journal of Medicine concluded:
On the one hand, the vaccine has high efficacy against certain HPV
types that cause life-threatening disease, and it appears to be safe;
delaying vaccination may mean that many women will miss an
opportunity for long-lasting protection. On the other hand, a cautious
approach may be warranted in light of important unanswered
questions about overall vaccine effectiveness, duration of protection,
and adverse effects that may emerge over time.
7 0
In addition to efficacy, the safety of the HPV vaccine is also unclear,
especially when given to men. The FDA only tested the vaccine's safety in
States: Implications for Developing a Vaccination Strategy, 33 SEXUALLY TRANSMITTED
DISEASE 502 (2006); see also Eileen F. Dunne, Prevalence of HPV Infection Among
Females in the United States, 297 JAMA 813 (2007); see generally HPV Fact Sheet,
supra note 1, at 2.
66. Dowling, supra note 4, at 72; see also Gostin & DeAngelis, supra note 65.
67. See Dowling, supra note 4, at 72.
68. Id.
69. Id.
70. See Law, supra note 35, at 1740 (quoting George F. Sawaya & Karen Smith-
McCune, HPV Vaccination-More Answers, More Questions, 356 NEw ENG. J. MED.
1991, 1993 (2007)).
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11,000 women over the five-year trial period.7 ' Although no serious side
72
effects were observed, questions still remain about long-term reactions. As
of September 30, 2010, there have been 17,160 reports of adverse effects
following Gardasil@ vaccination; 1,372 were serious reactions, including
fifty-six deaths and other complications, such as Guillain-Barre Syndrome,
blood clots and other effects requiring hospitalization or causing permanent
disability.73 It is important to note that most studies and reports regarding
the safety of the vaccine apply to women, not men.74
C. The Extreme Cost of Vaccination
1. Who Pays the Tab for One of the Most Expensive Vaccine Ever?
Requiring men to get the HPV vaccine is, first and foremost, a burden on
the health care system. On the heels of an economic recession7 5 and the
overhaul of the country's health care system,76 the cost effectiveness of a
procedure or measure must be part of any health care decision. Gardasil@,
the HPV vaccine manufactured by Merck, is one of the most expensive
71. See FDA Licenses New Vaccine for Prevention of Cervical Cancer, supra note
47.
72. See Dowling, supra note 4, at 72.
73. See Reports of Health Concerns Following HPV Vaccination, CTRS. FOR DISEASE
CONTROL & PREVENTION, http://www.cdc.gov/vaccinesafety/Vaccines/HPV/gardasil.html
(last visited Oct. 30, 2010). In 1989 Congress passed the national Childhood Vaccine
Injury Act which created the Vaccine Adverse Event Reporting System to collect
information about adverse reactions to vaccines. Id.
74. See FDA Approves New Indication for Gardasil , supra note 9; Bruce Sylvester,
Quadrivalent HPV Vaccine Gardasil Reduces Persistent Anogenital HPV Infection in
Men Who Have Sex With Men: Presented at IPV, NAT. AIDS TREATMENT ADVOCACY
PROJECT, http://www.natap.org/2009/newsUpdates/ 052009_02.htm (last visited Nov. 17
2010). To date, the only study on HPV vaccine in men was sponsored by Merck and
presented at the twenty-fifth International Papillomavirus Congress last month in
Sweden. This study concentrated on the efficacy, and not the safety of the vaccine. Id.
75. See Jon Hilsenrath, Worst Crisis Since '30s, With No End Yet in Sight, WALL ST.
J., Sept. 18, 2008, at AI, available at http://online.wsj.com/article/SB12216943161
7549947.html.
76. John Whitesides, Moderate Democrat Boosts Senate Health Bill, REUTERS.COM
(Nov. 20, 2009), http://www.reuters.com/article/healthNews/idUSN 1812587720091120.
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vaccines ever produced.n Gardasil@ must be injected in three doses over
six months to be effective.78  Since each dose costs approximately one
hundred thirty dollars, it is estimated that the vaccine could cost as much as
five hundred dollars when all injections are completed and fees are paid.
Other mandatory vaccines required for school enrollment cost far less than
Gardasil@, and only require one dose. For instance, private cost for
vaccinations for measles, mumps and rubella (MMR) cost fifty dollars per
dose; those for chicken pox cost seventy-seven dollars per dose; and those
for tetanus cost less than twenty dollars per dose.80 Although the future of
the HPV vaccine in men is still in the preliminary stages of debate, any
discussion about compelling such vaccination must be coupled with how the
government plans to finance such an expensive and potentially unnecessary
81vaccine.
Questions continue to circulate concerning the role of private and public
insurance in prevention of STIs as opposed to prevention of traditional
communicable diseases. Recent trends indicate that the financial burden has
been shifting from private to public insurers, which will encumber an
already overburdened system.82 Taxpayers who oppose paying for a vaccine
to prevent an STI, or who agree that vaccinating mere carriers is not cost-
effective, are likely to place pressure on their respective state legislatures to
77. ACS FAQ, supra note 22; CDC Vaccine Price List, CTRS. FOR DISEASE CONTROL
& PREVENTION, http://www.cdc.gov/nip/vfc/cdc vacpricelist.htm (last visited Oct. 14,
2010).
78. ACS FAQ, supra note 22. The American Cancer Society states that "[t]o be most
effective, one of the HPV vaccines should be given before a female has any type of
sexual contact with another person. Both are given in a series of 3 doses within 6
months." Id.
79. According to the American Cancer Society, "the drug company price for
Gardasil is $130 per dose, and Cervarix is $128 per dose." ACS FAQ, supra note 22;
Hodge & Gostin, supra note 34, at 845. The Center for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP) recommends vaccination for
girls aged eleven to twelve, although the series can be started as early as nine years old.
ACIP also recommends a "catch up" series for women aged thirteeen to twenty-six years
old. See Thomas C. Wright, The New HPV Vaccine: What the ObGyn Needs to Know, 19
J. FAM. PRAC. 1 (2007).
80. CDC Vaccine Price List, supra note 77.
81. ASHA FAQ,supra note 20.
82. Id.
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deny public funding.83 Because state legislatures are the primary leaders in
regulating health insurance, immunization laws vary by state and therefore
affect private insurance companies who rely on ACIP recommendations
when deciding what vaccines to cover.84
2. Compelling Men to be Vaccinated is not Cost Effective
In addition to the cost of the vaccine, the policy goals behind immunizing
men are questionable. Although studies continue to find that vaccinating
women is "within the threshold for good value," adding men to the equation
"[does] not outweigh the costs."8 5 A recent study by Harvard researchers
published in the British Medical Journal concluded that vaccinating men
against HPV does not appear to be cost effective.86 The study analyzed the
cost effectiveness of adding men to current vaccination programs.
Researchers used mathematical models based on data from clinical trials,
population studies, and cost data to measure the incremental cost
effectiveness ratios, which are expressed as cost quality adjusted life year
(QALY), a mathematical formula that measures the burden of disease on the
quality and the quantity of life lived.88 Vaccinating twelve-year-old girls -
assuming seventy-five percent get the shots and the vaccine lasts a lifetime -
83. Id.
84. Id Most private insurance companies include most, if not all, of ACIP
recommended vaccines in their benefit programs. Id.
85. Julie Steenhuysen, Giving Gardasil to Boys Not Cost Effective: Study, REUTERS
(Oct. 9, 2009), http://www.reuters.com/article/healthNews/idUSTRE59802520091009.
86. Jane J. Kim & Sue J. Goldie, Cost effectiveness analysis of including boys in a
human papillomavirus vaccination programme in the United States, 339 B.M.J. 3884
(2009), http://www.bmj.com/content/339/bmj.b3884.full.pdf See also Steenhuysen,
supra note 85.
87. Kim, supra note 86 at 1. Current programs include routine screening beginning
in women around the age of 20 or three years after their first sexual intercourse.
Vaccinating Boys Against Human Papillomavirus (HPV) Not Cost Effective, MED. NEWS
TODAY (Oct. 9, 2009), http://www.medicalnewstoday.com/articles/166903.php.
88. Kim, supra note 86, at 1; see Measuring Effectiveness and Cost Effectiveness:
the QALY, NAT. INST. FOR HEALTH AND CLINICAL EXCELLENCE (Apr. 20, 2010),
http://www.nice.org.uk/newsroom/features/measuringeffectivenessandcost
effectivenesstheqaly.jsp; see also Vaccinating Boys Against Human Papillomavirus
(HPV) Not Cost Effective, MED. NEWS TODAY (Oct. 9, 2009), http://www.medicalnews
today.com/articles/1 66903.php.
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will lead to a cost-effectiveness ratio of less than $50,000 per QALY.89
Under the same assumptions, adding men to the equation caused the ratio to
exceed $100,000.90
While some argue that the spread of HPV has turned into an epidemic,91
the 3,700 deaths per year from cervical cancer92 do not compare to the thirty
to fifty million deaths recorded during the 1918 influenza pandemic.93
Further, even though HPV is the main "etiological cause step" in cervical
cancer, there are other risk factors including giving birth, smoking, using
oral contraceptives, having numerous sexual partners, and having a weak
immune system. 94 The HPV vaccine does not affect any of these other
factors. Therefore, when taking all risk factors into account, compelling
men to be vaccinated against HPV would only slightly affect the number of
women infected with HPV or suffering from cervical cancer. It would
however, severely burden men by forcing them to take the unnecessary and
expensive trip to their doctor.
Researchers acknowledge that since the vaccine is new and additional
tests need to be conducted to learn more about it, additional heath benefits
may not be known. 95 Regardless, Jane Kim of the Harvard School of Public
Health, whose study appears in the British Medical Journal, says her results
imply that "there may be better uses and other health interventions that
89. Kim, supra note 86 at 3; see Measuring Effectiveness, supra note 88; see also
Vaccinating Boys, supra note 88.
90. Kim, supra note 86 at 3; see also Measuring Effectiveness, supra note 88;
Vaccinating Boys, supra note 88.
91. See generally, CTRS. FOR DISEASE CONTROL & PREVENTION, DEP'T OF HEALTH &
HUMAN SERVS., TRACKING THE HIDDEN EPIDEMICS 18 (2000), http://www.cdc.gov.std/
Trends2000/Trends2000.pdf. Study examines numerous STIs, including HPV, calling
them "hidden epidemics." Id. at 1.
92. Dowling, supra note 4, at 70.
93. See Survivors Remember 1918 Global Flu Pandemic, MSNBC.coM (Dec. 17,
2006), http://www.msnbc.msn.com/id/16194254/. The 1918 flu pandemic killed "at least
50 million people and perhaps as many as 100 million" people. Id.
94. See Dowling, supra note 4, at 70-71; see also J. Brisson et al., Risk Factors for
Cervical Intraepithelial Neoplasia: Differences Between Low - and High-Grade Lesions,
140 AM. J. EPIDEMIOL 700, 701, 704, 707 (1994).
95. Steenhuysen, supra note 85; see Measuring Effectiveness, supra note 88; see also
Vaccinating Boys, supra note 88.
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would increase health gains in the population." 96  It is not fiscally
responsible for the government, given the United States' current budget
situation and the rising costs of health care, to expend limited resources to
programs and initiatives that are not cost-effective.
VI. COMPELLING HPV VACCINATION IMPINGES ON PRIVACY RIGHTS
A. The Basic Right to Privacy
In addition to its constitutionality being questionable at best, mandatory
vaccination of mere carriers of a virus would impinge on the basic right to
privacy, a right which has been an integral part of our country's history. The
right to privacy is simple: it is the "right to be let [sic] alone."97 Before
Louis Brandeis was a Supreme Court Justice, he wrote one of the most
influential articles discussing privacy rights, The Right to Privacy, in which
he discusses the basic right and its limitations.98 Brandeis opens by stating
"the individual shall have full protection in person and in property . . . but it
has been found necessary from time to time to define anew the exact nature
and extent of such protection." 99 Writing this article in response to invasions
by government and the media, Brandeis contends the "traditional" right to
privacy, including protection of tangible items through the writs of battery,
libel and trespass, must be expanded to create a new right encompassing
intangible protection against assault and slander.'oo In support of this view,
he argues that it is the court's "purpose to consider whether the existing law
affords a principle which can properly be invoked to protect the privacy of
the individual; and, if it does, what the nature and extent of such protection
is."' 0 The nature and extent of such protection is precisely the point of
contention in current debate over HPV vaccination.
There are two sides to this debate. Proponents of vaccination would argue
for the HPV vaccine as an appropriate invasion into a man's privacy.
96. Steenhuysen, supra note 85; see also Kim, supra note 86; Vaccinating Boys,
supra note 88.
97. Samuel D. Warren & Louis Brandeis, The Right to Privacy, 4 HARv. L. REV.
193, 193-95 (1890).
98. See id. at 193, 195, 197.
99. Id. at 193.
100. See id. at 193-95.
101. Id. at 197.
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Opponents of compelled vaccination for men would argue that even viewing
the vaccination as a "public necessity," compelling a carrier of an infection
to be vaccinated is an invasion of personal privacy. As Brandeis would
contend, "[w]e must therefore conclude that the rights, so protected,
whatever their exact nature . . . are rights as against the world."l 02 The
evolution of the basic right to privacy must be protected against action to
compel virus carriers to be vaccinated, the newest form of government
intrusion.
B. American Courts Must Follow Precedent Protecting Privacy Rights
Early American case law addressed the competing interests of protecting
the public against disease and defending public rights against invasion of the
government by allowing school boards and state legislatures to enforce such
mandatory vaccination programs. 0 3 These early cases were issued during a
time when smallpox was a major epidemic contributing to a fatality rate of
approximately thirty-five percent of the population, and controlling its
spread protected the public at large.'4 The development of the HPV vaccine
has been said to be of "major public health importance" because of the
potential impact it could have on women's health. However true or untrue
that may be, compelling vaccination requires a balancing of private choice
and state interests.
The Tenth Amendment to the Constitution states that all powers not
delegated to the Federal government are reserved to the state.106 These
traditional police powers are reserved to states allowing for state control on
issues "relate[d] to the safety, health, morals, and general welfare of the
public." 07  The Supreme Court held that when a state exercises these
powers, public health should be balanced against "medical considerations,
102. Id. at 213.
103. See Jacobson v. Massachusetts, 197 U.S. 11, 25-26, 28, 31-32, 39-40 (1905).
Jacobson deals directly with the issue of compelling vaccination in the interest of the
public, while balancing the privacy rights of its citizens.
104. See Shaw, supra note 12, at 107.
105. James Colgrove, The Ethics and Politics of Compulsory HPV Vaccination, 355
NEW ENG. J. MED., 2389, 2389-90 (2006).
106. U.S. CONsT. amend. X.
107. Lochner v. New York, 198 U.S. 45, 53 (1905).
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personal autonomy, parental rights, and the religious and personal
philosophy of the individual."'os
The HPV vaccine debate highlights the tension between "civil liberties
and public health" concerns.109 Traditionally, the Supreme Court has been
hesitant to impinge on one's right of privacy.110 For example, in Griswold v.
Connecticut, the Supreme Court invalidated a state statute preventin the use
of contraceptives, on the premise that one has a right to privacy. " The
underpinnings of privacy in Griswold have set the stage for the modern
doctrine of privacy." 2 In his opinion, Justice William 0. Douglas argues
that protection from government intrusion into marital privacy was a
constitutional right, one that is a "penumbra" growing out of our
constitutional protections."i 3  Later decisions have noted the Griswold
Court's instruction: "governmental purpose to control or prevent activities
constitutionally subject to state regulation may not be achieved by means
which swee unnecessarily broadly and thereby invade the area of protected
freedom."" Although a federal mandate has not been introduced, the only
way a potential mandate could be implement would be A federal mandate
by invading the area of law normally governed by the state.
Proponents of mandatory vaccination in men and women argue that
cervical cancer poses a public health risk and society as a whole should do
everything possible to prevent the virus from spreading." 5 Although it is
108. Dowling, supra note 4, at 67; see Lochner, 198 U.S. at 53. See also Ross D.
Silverman, No More Kidding Around: Restructuring Non-Medical Childhood
Immunization Exemptions to Ensure Public Health Protection, 12 ANNALS HEALTH L.
277, 278 (2003).
109. Dowling, supra note 4, at 67, n. 18 (citing Lawrence 0. Gostin, PUB. HEALTH
LAW: POWER DUTY, RESTRAINT 21 (2000)).
110. See e.g., Griswold v. Connecticut, 381 U.S. 479 (1965); Stanley v. Georgia, 394
U.S. 557 (1969); Roe v. Wade, 410 U.S. 113 (1973); Kelley v. Johnson 425 U.S. 238
(1976); Cruzan v. Dir., Mo. Dep't of Health 497 U.S. 261 (1990); Lawrence v. Texas,
539 U.S. 558 (2003).
111. See Griswold, 381 U.S. at 480, 485.
112. See id.
113. Id. at 483, 484-86.
114. Williams v. Pryor, 220 F.Supp. 2d 1257, 1297 (N.D. Ala. 2002) (citing Griswold,
381 U.S. at 485).
115. Shaw, supra note 12, at 108.
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true that many women suffer from cervical cancer, it is hardly a public
health risk when compared to the millions affected by epidemics in the last
century.' 16 Furthermore, as discussed earlier, there are other factors that
impact a woman's chance of suffering from cervical cancer, and there are
screening precautions, such as a pap smear, that women can use to protect
themselves." 7 Even when taking into account all of these factors, they do
not outweigh the opposing argument that compelling immunization on
carriers is not only an infringement on one's privacy, but also runs counter
to public policy and what the American courts have permitted throughout
their history.
C. The Roe Effect
Privacy rights were again strengthened by the landmark decision Roe v.
Wade, where the Supreme Court set forth the precedent for other cases to
disallow state and federal restrictions on abortion by citing the
Constitution's right to privacy emanating from the Due Process Clause of
the Fourteenth Amendment.118 Justice Blackmun writing for the Court
asserted that the "right of privacy . . . found[] in the Fourteenth
Amendment's concept of personal liberty and restrictions upon state action .
. . is broad enough to encompass a woman's decision whether or not to
terminate her pregnancy."ll 9  This precedent firmly establishes that a
government should not compel a woman, or a man, to take action in regards
to their body that does not protect the public.
Citing Roe, courts have further recognized that "regulation[s] limiting ...
[fundamental] rights may be justified only by a 'compelling state interest' . .
. and that legislative enactments must be narrowly drawn to express only the
legitimate state interests at stake." 20 The Roe Court balanced the interest in
116. See Survivors Remember 1918 Global Flu Pandemic, supra note 93. The 1918
flu pandemic killed "at least 50 million people and perhaps as many as 100 million"
people. Id.
117. See Dowling, supra note 4, at 70-71; see also Brisson, supra note 94.
118. Roe v. Wade, 410 U.S. 113, 152-55 (1973). In Roe, the United States Supreme
Court concluded that the "right of privacy, whether it be founded in the Fourteenth
Amendment's concept of personal liberty and restrictions upon state action . . . or . . .in
the Ninth Amendment's reservation of rights to the people, is broad enough to encompass
a woman's decision whether or not to terminate her pregnancy." Id. at 153.
119. Id. at 153.
120. Women's Cmty. Health Ctr., Inc. v. Cohen, 477 F. Supp. 542, 545 (D. Me. 1979)
(citing Roe, 410 U.S. at 155).
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the mother's health against the interest of protecting life, concluding that
during the first trimester, "the abortion decision and its effectuation must be
left to the medical judgment of the pregnant woman's attending physician"
and "free of interference by the State." i Cases following Roe make clear
that "if the challenged state action does not impinge upon a woman's
decision to have an abortion and does not place obstacles in the path of
effectuating that decision, the regulation need only be justified by a rational
relationship to a legitimate state purpose."l22 With regard to the debate on
the HPV vaccine, compelling vaccination would only be justified under the
rationale set forth in Roe when there is a compelling state interest. This is
not present in the current debate.
Similarly, opponents of vaccinating men would argue that government
intrusion would restrict personal judgment pertaining to medical decisions.
Recognizing that the vaccine is currently approved, the decision to be
vaccinated should be left to the personal judgment of each man coupled with
solicited medical judgment from the man's physician. Any government
interference should only occur when a legitimate state interest is involved,
which is not the case, as discussed in Part 11.123
Vll. THE CONSTITUTIONAL STANDARD OF COMPELLING VACCINATION
A. Jacobson v. Massachusetts
Although the HPV vaccine is currently approved for permissive use, this
Note argues that the logical progression would involve a push for mandatory
vaccination.124 As discussed in Part 1II, the American medical community
has relied heavily on school-based mandates to compel vaccination.125 Even
with historic precedent and numerous local cases approving legislation to
compel vaccination, courts have allowed for exceptions based on religious,
121. Roe, 410 U.S. at 162-64.
122. Cohen, 477 F. Supp. at 545.
123. See Part II, supra.
124. See Law, supra note 35, at 1762-64. Herd immunity is achieved when an "entire
community is protected against a contagion because a sufficiently large percentage of the
group is immune." Id. at 1762. See also Shaw, supra note 12, at 108. Accepting the
premise that herd immunity is the next step after vaccine approval, Shaw notes that
proponents argue steps such as, "[v]accination are necessary in a public health sense, to
control disease." Id.
125. See Part III, supra.
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scientific, and philosophical beliefs.126 Historically, legislation mandating
vaccinations "for diseases transmitted through the air because such diseases
are much more difficult to combat; no specific behavior--other than simply
being in the same room as another infected person--makes a person more
susceptible to infection".127 Although these early decisions paved the way
for state legislatures to pass laws compelling vaccination for communicable
diseases, the judiciary did limit mandatory vaccination in some cases where
religious beliefs provided good reason for noncompliance.1 28
The Supreme Court's majority opinion in Jacobson v. Massachusetts laid
out the constitutional requirements for such decisions. 129 Jacobson was a
Massachusetts citizen, who, for philosophical reasons, opposed the
compulsory smallpox vaccine because he did not believe it worked.1 30 He
also objected to the compulsory vaccination law calling it "unreasonable,
arbitrary and oppressive, and therefore, hostile to the inherent right of every
freeman to care for his own body and health . . . ."' After refusing the
vaccine, he was charged and fined.132 Jacobson argued that he had a
126. Jonathan T. Scott, The Difficult Road to Compelling Vaccination for Sexually
Transmitted Diseases - How Gardasil and Those to Follow Will Change the Way that
States Require Inoculation, 97 Ky. L.J. 697, 707 (2009). Most courts addressed this issue
by allowing for exceptions to mandatory vaccination laws. Those that object to
vaccination have been making arguments since the nineteenth century objecting on
moral, intellectual and philosophical levels. Religious objectors carved out another group
of "anti-vaccinationists," who tend to receive far more protection under Jacobson and in
modem cases. Id. at 705-06.
127. Dowling, supra note 4, at 80. These diseases do not require additional behavior.
Merely being in the same room or walking by a person can result in a transfer of the
disease. Id.
128. Scott, supra note 126, at 701-02, 707-08. Most courts addressed this issue by
allowing for exceptions to mandatory vaccination laws. Id. at 706.
129. See Jacobson v. Massachusetts, 197 U.S. 11, 11 (1905) (holding that is a valid
exercise of police power to delegate to local boards of health authority to require, under
penalty, the vaccination of all citizens where it may be deemed necessary to the public
health and safety; and such necessity arises when smallpox is present in a community, or
its appearance may be reasonably apprehended). See also Dowling, supra note 4, at 68;
see also Scott, supra note 126, at 700.
130. Jacobson, 197 U.S. at 13-14.
131. Id. at 26.
132. Id. at 12-14.
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constitutional right under the Fourteenth Amendment to refuse compulsory
vaccinations.' 33 The Court disagreed stating that in pursuing the common
good, "a community has the right to protect itself against an epidemic of
disease which threatens the safety of its members."l 34
The Jacobson Court recognized there are limits to states' police powers
by laying out five criteria that legislatures must meet before requiring
compulsory vaccinations.' 35  The initial factor requires a "public health
necessity" to "prompt the restriction." 36 The Court notes that states cannot
exercise powers in "an arbitrary, unreasonable manner" or "go so far beyond
what [is] reasonably required for the safety of the public."' 37 Next, the
Court calls for a "reasonable relationship between the public health
intervention and the achievement of a legitimate public health objective.
Next, there must be a "real or substantial relation" between the safeguards
implemented and the public health concern, and that such safeguards are not
just a 'plain, palpable invasion of rights." 39 The fourth factor considers
whether the action or regulation is "proportional to the risk," findin
interventions that are "gratuitously onerous or unfair" unconstitutional.' 4
The final factor requires that the measure or vaccination cannot pose a health
risk to the individual. 141 Summing up this seminal decision, Jacobson
advances two notions: "that police powers authorize states to compel
vaccination for the public good, and that government power is only
constitutionally acceptable if exercised reasonably." 42
133. Id. at 13-14.
134. Jacobson, 197 U.S. at 28; see also Dowling, supra note 4, at 68.
135. See Dowling, supra note 4, at 68.
136. Id.; see also Jacobson, 197 U.S. at 28-29.
137. Jacobson, 197 U.S. at 28; see Dowling, supra note 4, at 68.
138. Dowling, supra note 4, at 68; see Jacobson, 197 U.S. at 26-27.
139. Jacobson, 197 U.S. at 31.
140. Dowling, supra note 4, at 68; Hodge & Gostin, supra note 34, at 856.
141. See Dowling, supra note 4, at 68; see also Jacobson, 197 U.S. at 39.
142. Dowling, supra note 4, at 68.
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B. The HPV Vaccine Does Not Pass Muster Under Jacobson
The American legal system aims to balance the rights of its citizens
against the goals of society without upsetting either.143 While preventing
disease is important to society, legislatures that compel vaccinations must
thoroughly evaluate all the risks, benefits, and consequences before making
such a decision. Legislatures should use the factors outlined by the Supreme
Court in Jacobson as their guide. As noted above, Jacobson sets out the
factors/requirements that mandatory action must meet in order to be
constitutional. As discussed in Part IV of this Note, compelling the use of
the HPV vaccine would fail the final Jacobson factor regarding the safety
and efficacy of the vaccine. In addition, legislation compelling the use of
the HPV vaccine also fails to meet the four remaining Jacobson factors, as
discussed below. Proponents of mandatory vaccination argue that cervical
cancer is a public health concern that could be prevented by vaccinating
young girls and men before they become sexually active, creating herd
immunity.'" Studies have shown that to achieve herd immunity, between
seventy-five and ninety percent of the population must be vaccinated. 145
The only way to achieve such a large percentage is to mandate vaccinations
of both men and women. Opponents of mandatory vaccinations argue that
the vaccine does not address a health necessity, is not safe or effective, and
would be unconstitutional if compelled.
1. Cervical Cancer Does Not Implicate a Health Necessity
A Jacobson analysis is triggered by a "public heath necessity."l46
Although HPV can lead to cancer in some individuals, for most, it
disappears without the person ever being aware of the infection.147 Studies
indicate that 3,700 to 3,900 women die each year from cervical cancer,148
143. J. ScoTr HARR & KAREN M. HESS, CONSTITUTIONAL LAW AND THE CRIMINAL
JUSTICE SYSTEM 38 (2008).
144. See Law, supra note 35 at 1761-62; see also Shaw, supra note 12, at 108.
145. See Law, supra note 35 at 1761-62; see also Shaw, supra note 12, at 108.
146. Dowling, supra note 4, at 68.
147. See generaly HP V Fact Sheet, supra note 1.
148. See Dowling, supra note 4, at 80 (estimating 3,700 annual deaths from cervical
cancer); see also Allen Craig, Abigail English, Frederci E. Shaw & Lance Rodewald,
New Adolescent Vaccines: Legal and Legislative Issues, 35 J.L. MED. & ETHICS 106, 106
(2007) (noting 3,900 deaths from cervical cancer annually); see generally HPV Fact
Sheet, supra note 1.
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representing only ".001 [% of the population in the United States or .002[%]
of the female population." 49 Though it is a horrible disease, HPV is clearly
not a public health epidemic. In contrast, both measles and small pox were
communicable diseases that had major impacts on the safety of the public,
and therefore, justified compulsory vaccinations.'so
2. No "Reasonable Relationship" Exists Between Compelling
Vaccination and Achieving the Goal ofDecreasing Cervical Cancer
Next, the Jacobson court examined the relationship between the "public
health intervention and achievement of a legitimate public heath
objective."' 5 ' Even assuming a court would find that cervical cancer is a
149. See Dowling, supra note 4, at 80 (estimating 3,700 annual deaths from cervical
cancer); see also Craig, supra note 148, at 106; see generally HPV Fact Sheet, supra note
I.
150. See How Poxviruses Such as Smallpox Evade the Immune System,
SCIENCEDAILY.COM, http://www.sciencedaily.com/releases/2008/01/080131122956.htm
(last visited Nov. 7, 2010) (asserting that "[t]he [smallpox] virus is estimated to have
caused between 300 million and 500 million deaths in the 20' century alone."); see also
WORLD HEALTH ORG., FACT SHEET ON MEASLES 1 (2009), http://www.who.int/
mediacentre/factsheets/fs286/en/ (explaining that measles is a "highly contagious, serious
disease" and caused "nearly 450 deaths every day" in 2008); see also Shaw, supra note
12, at 107 (identifying a smallpox death rate of thirty-five percent). Mandates for
vaccinations against dangerous, highly communicable diseases are much easier to justify.
Oral polio is an example from the past. Oral polio vaccine was, up to about the year 2000,
required in all 50 states (an injectable form of polio vaccine succeeded it). The oral
vaccine contained (and continues to contain, as it is used in other countries) live virus and
carries with it a tiny risk (perhaps about 1 in 2.4 million in the United States) of
developing paralysis from the vaccine virus itself. On the other hand, in 2000, an
American child being vaccinated with oral polio vaccine faced virtually no risk of
infection with wild polio virus, since it had been virtually eliminated from the Western
hemisphere and was increasingly rare in the rest of the world. Thus, in 2000, parents
could have made a rational decision for their child to avoid any risk of vaccine-induced
paralysis by refusing vaccination and allowing their child to free-ride on the vaccine-
induced immunity of others. If enough parents took that same course, the population
would experience a gradual increase in susceptibility to polio virus. Over time, assuming
the virus continued to circulate in the world, an outbreak of polio might occur in the U.S.
population. It is in this situation, mandatory vaccination against dangerous highly
communicable diseases, when the interests of parents as individuals conflict with the
interests of the whole, that the justification for vaccination mandates are at their
strongest. Id. at 108.
151. Dowling, supra note 4, at 68.
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public health necessity, it would not find a reasonable relationship between
vaccinating carriers of a virus and those who develop cervical cancer.
Vaccinating men, who are mere carriers, makes the discussion more
attenuated in light of the second factor's need to show a reasonable
relationship between the intervention and public health objectives.
Curtailing the spread of HPV is an important objective, but is one that
encompasses many more facets than just mandating a vaccine to a large
portion of the population.
Unlike diseases such as smallpox or the chickenpox, HPV is not an
airborne, highly infectious disease, posing no immediate risk to children at
schools.152 Mandatory vaccinations that would protect the interests of the
public as a whole prevailed over individual freedoms when smallpox
vaccinations were debated.'53 Most vaccines that are mandatory for school
enrollment "protect against highly contagious diseases that cause significant
morbidity and mortality and threaten both the individual and the
community."l54 Acknowledging that the HPV vaccine does prevent the
prevalence of HPV infections, it is still unclear whether HPV is a true threat
to the general welfare.' 55
A similar policy involving the vaccination of one segment of the
population for the primary purpose of reducing the incidence of a disease in
another segment was debated in regards to the rubella vaccine.156  The
vaccine is given to all children to reduce the incidence of "congenital defects
in infants born to women who contract rubella during pregnancy."' 5 7
However, "sexually transmitted diseases can generally be avoided through a
152. See Hodge & Gostin, supra note 34, at 845; see also Dowling, supra, note 4, at
81 (noting that "HPV can be contained through behavioral changes and is not
communicable through ordinary daily interactions.").
153. See Shaw, supra note 12, at 107.
154. Dowling, supra, note 4, at 81.
155. Id.
156. James Colgrove, Compulsory HPV Vaccination, 356 NEw ENGL. J. OF MED.
1047, 1074 (Mar. 8, 2007), http://www.nejm.org/doi/pdf/10.1056/NEJMcG63713.
157. Id
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specific behavior change which an individual usually has full control
over." 58
A more recent debate concerning the Hepatitis B vaccine is more
comparable to the HPV vaccine because it also seeks to prevent the spread
of a sexually-transmitted disease.159 However, Hepatitis B is not merely a
sexually transmitted disease; it can also be contracted through blood and
bodily fluid transmission.16 0  One can refrain from contracting HPV by
changing sexual behavior, an option that is not always successful in
preventing Hepatitis B transmission. Those who "accept[] the view that
such laws are justified only by the state's prerogative to protect the whole,
and are not justified by the state's desire to protect individuals from the
consequences of their own behavior" have a hard time accepting laws
mandating vaccines for viruses transferred through behavior. 16 1
3. The Action is Not Proportional to the Prevalence of Cervical
Cancer
The Jacobson Court finally examined whether government action was
"proportional to the risk" of the disease.162 A court cannot find that the
proposed action of vaccinating every adolescent against a virus is
proportional if HPV only causes cancer in 0.002% of the population.'
63
Mandating carriers of a virus to pay for such an expensive vaccine is not
proportional, especially in light of other preventative measures such as pap
smears, which have been effective in detecting abnormal cells and cervical
cancer for over fifty years.164 A stronger argument for proportionality may
158. See Dowling, supra note 4, at 80. The recent debate concerning the Hepatitis B
vaccine is more comparable to the HPV vaccine because it also seeks to prevent the
spread of a sexually-transmitted disease. Id.
159. See Dowling, supra note 4, at 80.
160. See Dowling, supra note 4, at 80, n.156 (citing Richard K Zimmerman, Ethical
Analysis ofHPV Vaccine Policy Options, 24 VACCINE 4812, 4815 (2006)).
161. See Shaw, supra note 12, at 108.
162. Dowling, supra note 4, at 68.
163. See Dowling, supra note 4, at 68, 80 (estimating 3,700 annual deaths from
cervical cancer); see also Craig, supra note 148, at 106; see generally HPV Fact Sheet,
supra note 1.
164. Law, supra note 35, at 1735-36. Since the 1950s doctors have used this
procedure to identify potential abnormalities in the cervix, which could lead to an
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be to mandate the HPV vaccine for girls since they risk being directly
affected by cervical cancer; however, this argument is not without gaps. The
American College of Obstetricians and Gynecologists (ACOG) guidelines
recently increased the age recommendation for having annual pap smears,
but the exam "continue[s] to be essential to detect cervical cancers."'165 In
addition, a new DNA test was revealed that could be more effective than a
pap smear.166 The ACOG notes that "only 0.1 percent of cervical cancer
occurs in women under 21 years of age in part . . . because young women's
immune systems are strong enough to fight off HPV before it causes
cancer." The HPV vaccine is not a shortcut to prevention, only an added
level of protection because there is still a chance of an irregular pap smear
even after vaccination.168 Further "most pap test abnormalities are caused
by HPV types not preventable with current vaccines."1 69 Thus, if up to
ninety percent of HPV infections are "cleared on their own in adolescents
within a few years" 170 and women are still urged to go to the gynecologists
infection or cervical cancer. Today, doctors annually perform more than fifty million pap
smear procedures and only five percent are abnormal requiring additional tests. Id. at
1736. These traditional procedures have benefited women and are proportional.
165. NAT'L CANCER INST., PAP TEST FACT SHEET 1 (2009), http://www.cancer.gov/
images/documents/6e8424db- 12f5-4b8a-bl 60-e8dOl 0fd6026/ Fs5_1 6.pdf; see Law,
supra note 35, at 1735; see also Lauren Cox & Dr. Joshua Hundert, New Cervical Cancer
Screening Guidelines: No More 'Annual' Pap Smears, GOOD MORNING AM. (Nov.20,
2009), http://abcnews.go.com/GMA/OnCall/ guidelines-ditch-annual-pap-
smears/story?id=9131632.
166. Marie Savard, Battling Cervical Cancer: DNA Test More Effective Than Pap
Smear, GOOD MORNING AM. (Nov. 20, 2009), http://abcnews.go.com/GMA/OnCall/
story?id=7273065&page= 1.
167. See Cox & Hundert, supra note 165.
168. See generally Julia Brotherton & Stella Heley, Abnormal Pap Tests After the
HPV Vaccine, 38 AUST. FAM. PHYSICIAN 977 (2009), http://www.racgp.org.
au/afp/200912/200912heley.pdf. Brotherton and Heley research "why a substantial
number of young women who have been vaccinated with the HPV vaccine will still have
Pap test abnormalities." Id. See also Deborah Kotz, The HPV Vaccine and Pap Results,
U.S. NEWS AND WORLD REP. (Mar. 10, 2008), http://health.usnews.com/health-news/
blogs/on-women/2008/3/10/the-hpv-vaccine-and-pap-results (noting that even after the
HPV vaccine, women still need to go get pap smears).
169. See generallv Brotherton & Heley. supra note 168.
170. See generally Cox & Hundert, supra note 165.
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for annual pap smears after their twenty-first birthday, then mandating
vaccination of a carrier group seems overly burdensome and unnecessarily
expensive when the target group continues to adhere to traditional practices.
VIll. WHERE STATES STAND? STATE LEGISLATURES DIFFER OVER
VACCINATION
There is no current legislation pending that would mandate the HPV
vaccination for men, but that is most likely due to the fact that the vaccine
was only recently approved for use in men. Once a vaccine is approved by
the CDC and recommended by the ACIP, states begin to debate over
requirements and mandates. Some state legislatures have granted their
state's health departments the power to create mandates and requirements.
Debate at the state level has focused on compelling girls to be vaccinated for
school admission, with even HPV vaccine supporters citing concerns about
safety, cost and parental rights. 172 States that make the vaccine mandatory
"must also address funding issues, including for Medicaid and SCHIP
coverage and youth who are uninsured, and whether to require coverage by
insurance plans." 73
Shortly after the CDC's approval of the HPV vaccine in women,
Michigan became the first state senate to introduce legislation requiring the
HPV vaccine for sixth grade girls, but the bill was not enacted. As of
September 2009, forty-one states and the District of Columbia have
introduced legislation to "require, fund or educate the public" about the HPV
vaccine. At least nineteen states have enacted such legislation.176 Other
states, such as New Hampshire and South Dakota, have taken another
approach, providing the vaccine at no cost to girls under the age of
171. HPV Vaccine: State Legislation and Statutes, NAT. CONF. ST. LEG.,
http://www.ncsl.org/default.aspx?tabid= 14381 (last visited Nov. 7, 2010).
172. Id.
173. Id. "The HPV vaccine is available through the federal Vaccine for Children
(VFC) program in all 50 states . . . and Washington, DC." Id. VFC provides vaccines for




176. HP V Vaccine: State Legislation and Statutes, supra note 17 1.
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eighteen. 17 7 Currently, only Virginia and Washington, D.C., have approved
school attendance mandates for sixth-grade girls allowing parents an "opt-
out" for any reason.'7 Although these school-based mandates provide
parents with an opt-out, this trend moves the debate in a direction that would
open the door to compelling vaccination for men. Eventually state
governments may begin mandating sixth-grade boys to receive the HPV
vaccine to be eligible for school attendance. Such state intervention would
grossly exceed the traditional justifications for compelling vaccinations. As
the debate continues, legislators must think through this issue carefully and
consider actual public harm.
IX. CONCLUSION
After all the arguments are debated and the factors considered, there is no
reason to rationally support extending mandatory HPV vaccination to men.
Opponents are not arguing the vaccine should not be available, but rather
that it should not be mandatory for school enrollment. The government
should not be in the business of mandating vaccination to carriers of a virus
when the threat to the public is not imminent or serious. Not only would
such action be unconstitutional, but questions also remain regarding the
safety and efficacy of the vaccine. In addition, the cost of implementing
such a requirement would be overly burdensome to an already stretched
healthcare system. Recognizing that mandatory vaccination for
communicable viruses does benefit the public, the government should not
intervene when a virus can be curbed by changing behavior and can be
detected and treated by more cost-effective means, such as pap smears.
Therefore, compelled HPV vaccination should not be implemented by the
government and efforts to stop such action should be supported by all
Americans.
177. Id.
178. See HPV Vaccine a Suggestion, supra note 8.
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